StoryCorps facilitators Cindy Murphy and Kate Wingate traveled to Portland, Oregon this week to conduct two days of Door-to-Door interviews in partnership with the Oregon Health & Science University (OHSU) Cancer Institute. Ten years after the introduction of Gleevec, a drug used to treat gastrointestinal stromal tumors (GIST) and chronic myeloid leukemia (CML), OHSU sponsored StoryCorps’ visit in coordination with their GIST patient awareness week. As OHSU is a major center for the development of Gleevec, Kate and Cindy had the opportunity to record not only the stories of GIST and CML survivors, but also of the doctors and researchers who helped make their survival possible.
All posts including Oregon Health & Science University Cancer Institute
Posted by Kate on May 16, 2008, from Portland, Oregon
Community Partners: Oregon Health & Science University Cancer Institute
